Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-28,316
Closed -$3.16M 1674
2025
Q3
$3.16M Buy
28,316
+20,148
+247% +$2.4M 0.03% 567
2025
Q2
$985K Buy
+8,168
New +$988K 0.01% 967
2024
Q2
Sell
-11,488
Closed -$1.27M 1641
2024
Q1
$1.27M Buy
+11,488
New +$1.07M 0.01% 866
2023
Q4
Sell
-9,206
Closed -$646K 1630
2023
Q3
$646K Sell
9,206
-36,252
-80% -$2.52M 0.01% 1152
2023
Q2
$3.02M Buy
+45,458
New +$2.76M 0.02% 644
2022
Q3
Sell
-12,597
Closed -$551K 1993
2022
Q2
$551K Buy
+12,597
New +$608K 0.01% 1311

Other funds holding ESAB

Michael Gelband's ESAB Position: Q4 2025 in Review

Michael Gelband sold out of ESAB (ESAB) in Q4 2025, closing a stake of 28,316 shares — an estimated $3.16M sold.

Michael Gelband first reported a position in ESAB in Q2 2022 and held it in 6 quarters. The position peaked at $3.16M in Q3 2025. 359 funds tracked by Wall St. Rank hold ESAB as of Q4 2025.

  • Michael Gelband reported no remaining ESAB position as of Q4 2025 after selling out during the quarter.
  • Michael Gelband sold 28,316 ESAB shares in Q4 2025, an estimated $3.16M.
  • Michael Gelband first reported a position in ESAB in Q2 2022 and held it in 6 quarters.
  • Michael Gelband's ESAB position peaked at $3.16M in Q3 2025.
  • 359 funds tracked by Wall St. Rank held ESAB as of Q4 2025.

Based on ExodusPoint Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.